Answers are grounded in this paper and cite their sources.
Metformin treatment in patients with T2DM was associated with a reduced risk of NPDR, and a potential trend was found for a reduced STDR risk in patients who had previously been diagnosed with NPDR. Combining metformin with DPP-4i seemingly had a significantly beneficial effect against NPDR risk, particularly when aDCSI scores were low, and when metformin was prescribed early after T2DM diagnosis. These results may recommend metformin for early treatment of T2DM.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: